Aprepitant Versus Gabapentin Prophylaxis for Postoperative Nausea and Vomiting in Laparoscopic Gynecological Surgeries

clinical trial

Details

Instance of: clinical trial
Start time: August 2015
End time: March 2016
Country: Egypt
Main subject: vomiting, postoperative nausea and vomiting, nausea
clinical trial phase: phase II clinical trial, phase III clinical trial
maximum age: 45
minimum age: 18
number of participants: 150
research intervention: combined anesthetic, (RS)-cyclophosphamide, fosaprepitant
short name: PONV
study type: interventional study
title: Aprepitant Versus Gabapentin Prophylaxis for Postoperative Nausea and Vomiting in Laparoscopic Gynecological Surgeries

Nothing in the MetaHistoryBook collection references this item yet.